Form 4: STERIS Executive Insider Transaction Report

VP Lindsey McGowan acquired 1,155 shares and 4,036 stock options as part of a routine equity compensation plan.

Summary

• Lindsey McGowan, VP, Chief Compliance & Quality Officer at STERIS plc, reported a change in beneficial ownership on June 2, 2026.
• The transaction involved the acquisition of 1,155 ordinary shares and 4,036 employee stock options.
• 329 shares were withheld by the company to satisfy tax obligations related to the vesting of restricted shares.
• Following these transactions, the reporting person holds 5,656 ordinary shares directly and 255 share equivalents via a 401(k) plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing reflecting routine executive compensation rather than a strategic shift or market-moving event.

Positives

• The acquisition of equity by a key executive aligns management interests with long-term shareholder value.
• The stock options have a multi-year vesting schedule (2027-2030), encouraging long-term retention.

Negatives

• The withholding of 329 shares for tax purposes is a standard administrative action but reduces the net increase in direct share ownership.

Risks

• Future value of the acquired stock options is dependent on the company's share price exceeding the $230.74 exercise price.

Future Outlook

The filing does not provide forward-looking financial guidance, as it is a standard disclosure of executive equity compensation.

Industry Context

StockSavvy.ai notes that this filing represents standard executive compensation practices within the medical device and sterilization services sector, where equity-based incentives are common to retain high-level compliance and quality leadership.

Comparison to Industry Standards

• The use of restricted stock units and stock options with multi-year vesting is consistent with compensation structures at peer companies like Baxter International and Becton Dickinson.
• Tax withholding at vesting is a standard industry practice for public company equity plans.

Stakeholder Impact

• Shareholders may view the alignment of executive compensation with long-term performance as a positive governance signal.

Next Steps

• Vesting of restricted shares on June 4, 2027.
• First exercisable date for stock options on June 2, 2027.

Key Dates

Keywords

STERIS, STE, Insider Trading, Form 4, Equity Compensation, Executive Compensation